PCJ Investment Counsel’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,000
Closed -$2.43M 79
2023
Q1
$2.43M Buy
5,000
+3,500
+233% +$1.73M 0.96% 35
2022
Q4
$768K Sell
1,500
-7,500
-83% -$3.94M 0.33% 67
2022
Q3
$4.37M Buy
9,000
+2,500
+38% +$1.22M 2.14% 16
2022
Q2
$3.04M Buy
+6,500
New +$2.89M 1.51% 24
2021
Q2
Sell
-3,000
Closed -$1.26M 76
2021
Q1
$1.26M Buy
+3,000
New +$1.2M 0.49% 45
2020
Q3
Sell
-5,000
Closed -$1.94M 83
2020
Q2
$1.94M Buy
+5,000
New +$1.87M 0.94% 31

Other funds holding HUM

PCJ Investment Counsel's HUM Position: Q2 2023 in Review

PCJ Investment Counsel sold out of Humana (HUM) in Q2 2023, closing a stake of 5,000 shares — an estimated $2.43M sold.

PCJ Investment Counsel first reported a position in HUM in Q2 2020 and held it in 6 quarters. The position peaked at $4.37M in Q3 2022. 1,070 funds tracked by Wall St. Rank hold HUM as of Q2 2023.

  • PCJ Investment Counsel reported no remaining Humana position as of Q2 2023 after selling out during the quarter.
  • PCJ Investment Counsel sold 5,000 Humana shares in Q2 2023, an estimated $2.43M.
  • PCJ Investment Counsel first reported a position in Humana in Q2 2020 and held it in 6 quarters.
  • PCJ Investment Counsel's Humana position peaked at $4.37M in Q3 2022.
  • 1,070 funds tracked by Wall St. Rank held Humana as of Q2 2023.

Based on PCJ Investment Counsel's 13F filing for Q2 2023, filed 10 Aug 2023.